Green hemostatic sponge-like scaffold composed of soy protein and chitin for the treatment of epistaxis

Epistaxis is one of the most common otorhinolaryngology emergencies worldwide. Although there are currently several treatments available, they present several disadvantages. This, in addition to the increasing social need of being environmentally respectful, led us to investigate whether a sponge-li...

Full description

Bibliographic Details
Main Authors: Jon Jimenez-Martin, Kevin Las Heras, Alaitz Etxabide, Jone Uranga, Koro de la Caba, Pedro Guerrero, Manoli Igartua, Edorta Santos-Vizcaino, Rosa Maria Hernandez
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Materials Today Bio
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590006422000710
_version_ 1818507581499375616
author Jon Jimenez-Martin
Kevin Las Heras
Alaitz Etxabide
Jone Uranga
Koro de la Caba
Pedro Guerrero
Manoli Igartua
Edorta Santos-Vizcaino
Rosa Maria Hernandez
author_facet Jon Jimenez-Martin
Kevin Las Heras
Alaitz Etxabide
Jone Uranga
Koro de la Caba
Pedro Guerrero
Manoli Igartua
Edorta Santos-Vizcaino
Rosa Maria Hernandez
author_sort Jon Jimenez-Martin
collection DOAJ
description Epistaxis is one of the most common otorhinolaryngology emergencies worldwide. Although there are currently several treatments available, they present several disadvantages. This, in addition to the increasing social need of being environmentally respectful, led us to investigate whether a sponge-like scaffold (SP–CH) produced from natural by-products of the food industry — soy protein and β-chitin — can be employed as a nasal pack for the treatment of epistaxis. To evaluate the potential of our material as a nasal pack, it was compared with two of the most commonly used nasal packs in the clinic: a basic gauze and the gold standard Merocel®. Our SP-CH presented great physicochemical and mechanical properties, lost weight in aqueous medium, and could even partially degrade when incubated in blood. It was shown to be both biocompatible and hemocompatible in vitro, clearing up any doubt about its safety. It showed increased blood clotting capacity in vitro, as well as increased capacity to bind both red blood cells and platelets, compared to the standard gauze and Merocel®. Finally, a rat-tail amputation model revealed that our SP-CH could even reduce bleeding time in vivo. This work, carried out from a circular economy approach, demonstrates that a green strategy can be followed to manufacture nasal packs using valorized by-products of the food industry, with equal or even better hemostatic properties than the gold standard in the clinic.
first_indexed 2024-12-10T22:20:15Z
format Article
id doaj.art-7d6931be3ebc4126a70411d736761a5e
institution Directory Open Access Journal
issn 2590-0064
language English
last_indexed 2024-12-10T22:20:15Z
publishDate 2022-06-01
publisher Elsevier
record_format Article
series Materials Today Bio
spelling doaj.art-7d6931be3ebc4126a70411d736761a5e2022-12-22T01:31:20ZengElsevierMaterials Today Bio2590-00642022-06-0115100273Green hemostatic sponge-like scaffold composed of soy protein and chitin for the treatment of epistaxisJon Jimenez-Martin0Kevin Las Heras1Alaitz Etxabide2Jone Uranga3Koro de la Caba4Pedro Guerrero5Manoli Igartua6Edorta Santos-Vizcaino7Rosa Maria Hernandez8NanoBioCel Research Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de La Universidad 7, 01006 Vitoria Gasteiz, SpainNanoBioCel Research Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de La Universidad 7, 01006 Vitoria Gasteiz, Spain; Bioaraba, NanoBioCel Research Group, Vitoria Gasteiz, SpainBIOMAT Research Group, University of the Basque Country (UPV/EHU), Escuela de Ingeniería de Gipuzkoa, Plaza de Europa 1, 20018 Donostia-San Sebastián, SpainBIOMAT Research Group, University of the Basque Country (UPV/EHU), Escuela de Ingeniería de Gipuzkoa, Plaza de Europa 1, 20018 Donostia-San Sebastián, SpainBIOMAT Research Group, University of the Basque Country (UPV/EHU), Escuela de Ingeniería de Gipuzkoa, Plaza de Europa 1, 20018 Donostia-San Sebastián, Spain; BCMaterials, Basque Center for Materials, Applications and Nanostructures, UPV/EHU Science Park, 48940, Leioa, SpainBIOMAT Research Group, University of the Basque Country (UPV/EHU), Escuela de Ingeniería de Gipuzkoa, Plaza de Europa 1, 20018 Donostia-San Sebastián, Spain; BCMaterials, Basque Center for Materials, Applications and Nanostructures, UPV/EHU Science Park, 48940, Leioa, Spain; Proteinmat Materials SL, Avenida de Tolosa 72, 20018 Donostia-San Sebastian, SpainNanoBioCel Research Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de La Universidad 7, 01006 Vitoria Gasteiz, Spain; Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Institute of Health Carlos III, Madrid, Spain; Bioaraba, NanoBioCel Research Group, Vitoria Gasteiz, SpainNanoBioCel Research Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de La Universidad 7, 01006 Vitoria Gasteiz, Spain; Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Institute of Health Carlos III, Madrid, Spain; Bioaraba, NanoBioCel Research Group, Vitoria Gasteiz, Spain; Corresponding author. NanoBioCel Research Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria Gasteiz, Spain.NanoBioCel Research Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de La Universidad 7, 01006 Vitoria Gasteiz, Spain; Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Institute of Health Carlos III, Madrid, Spain; Bioaraba, NanoBioCel Research Group, Vitoria Gasteiz, Spain; Corresponding author. NanoBioCel Research Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria Gasteiz, Spain.Epistaxis is one of the most common otorhinolaryngology emergencies worldwide. Although there are currently several treatments available, they present several disadvantages. This, in addition to the increasing social need of being environmentally respectful, led us to investigate whether a sponge-like scaffold (SP–CH) produced from natural by-products of the food industry — soy protein and β-chitin — can be employed as a nasal pack for the treatment of epistaxis. To evaluate the potential of our material as a nasal pack, it was compared with two of the most commonly used nasal packs in the clinic: a basic gauze and the gold standard Merocel®. Our SP-CH presented great physicochemical and mechanical properties, lost weight in aqueous medium, and could even partially degrade when incubated in blood. It was shown to be both biocompatible and hemocompatible in vitro, clearing up any doubt about its safety. It showed increased blood clotting capacity in vitro, as well as increased capacity to bind both red blood cells and platelets, compared to the standard gauze and Merocel®. Finally, a rat-tail amputation model revealed that our SP-CH could even reduce bleeding time in vivo. This work, carried out from a circular economy approach, demonstrates that a green strategy can be followed to manufacture nasal packs using valorized by-products of the food industry, with equal or even better hemostatic properties than the gold standard in the clinic.http://www.sciencedirect.com/science/article/pii/S2590006422000710EpistaxisNasal packHemostasisSustainability
spellingShingle Jon Jimenez-Martin
Kevin Las Heras
Alaitz Etxabide
Jone Uranga
Koro de la Caba
Pedro Guerrero
Manoli Igartua
Edorta Santos-Vizcaino
Rosa Maria Hernandez
Green hemostatic sponge-like scaffold composed of soy protein and chitin for the treatment of epistaxis
Materials Today Bio
Epistaxis
Nasal pack
Hemostasis
Sustainability
title Green hemostatic sponge-like scaffold composed of soy protein and chitin for the treatment of epistaxis
title_full Green hemostatic sponge-like scaffold composed of soy protein and chitin for the treatment of epistaxis
title_fullStr Green hemostatic sponge-like scaffold composed of soy protein and chitin for the treatment of epistaxis
title_full_unstemmed Green hemostatic sponge-like scaffold composed of soy protein and chitin for the treatment of epistaxis
title_short Green hemostatic sponge-like scaffold composed of soy protein and chitin for the treatment of epistaxis
title_sort green hemostatic sponge like scaffold composed of soy protein and chitin for the treatment of epistaxis
topic Epistaxis
Nasal pack
Hemostasis
Sustainability
url http://www.sciencedirect.com/science/article/pii/S2590006422000710
work_keys_str_mv AT jonjimenezmartin greenhemostaticspongelikescaffoldcomposedofsoyproteinandchitinforthetreatmentofepistaxis
AT kevinlasheras greenhemostaticspongelikescaffoldcomposedofsoyproteinandchitinforthetreatmentofepistaxis
AT alaitzetxabide greenhemostaticspongelikescaffoldcomposedofsoyproteinandchitinforthetreatmentofepistaxis
AT joneuranga greenhemostaticspongelikescaffoldcomposedofsoyproteinandchitinforthetreatmentofepistaxis
AT korodelacaba greenhemostaticspongelikescaffoldcomposedofsoyproteinandchitinforthetreatmentofepistaxis
AT pedroguerrero greenhemostaticspongelikescaffoldcomposedofsoyproteinandchitinforthetreatmentofepistaxis
AT manoliigartua greenhemostaticspongelikescaffoldcomposedofsoyproteinandchitinforthetreatmentofepistaxis
AT edortasantosvizcaino greenhemostaticspongelikescaffoldcomposedofsoyproteinandchitinforthetreatmentofepistaxis
AT rosamariahernandez greenhemostaticspongelikescaffoldcomposedofsoyproteinandchitinforthetreatmentofepistaxis